Nick Richitt

Nick Richitt is Global Co-Head of Healthcare Investment Banking at J.P. Morgan, where he advises leading healthcare companies, sponsors, and management teams on mergers, acquisitions, and capital markets transactions. Having built J.P. Morgan's healthcare services practice into a top-ranked franchise before his 2026 elevation to co-lead the broader healthcare group, Richitt brings a deep understanding of the sector's strategic and financial dynamics to some of its most consequential deals.

With more than two decades of experience spanning over 250 transactions, Richitt has advised on landmark healthcare deals including Signify Health's roughly $8 billion sale to CVS Health, the approximately $17 billion buyout of Athenahealth by Bain Capital and Hellman & Friedman, and the merger of Ciox Health with Datavant. He joined J.P. Morgan in 2023 from Deutsche Bank, where he served as Global Co-Head of Healthcare Investment Banking, and earlier held roles at SunTrust Robinson Humphrey and Oppenheimer.